-NSI-189 Showed Durable Functional Recovery in a Rodent Model of Ischemic Stroke-
-NSI-189 Promoted Synaptic Remodeling After Stroke–
GERMANTOWN, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused